Home › Funds › Cormorant Asset Management, LP › VNDA
Cormorant Asset Management, LP position in VNDA
VANDA PHARMACEUTICALS INC · Health Care
Cormorant Asset Management, LP reported holding 962,898 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$19.2M, representing 1.37% of its reported portfolio and ranking #22 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's VNDA position evolved
Cormorant Asset Management, LP first disclosed a stake in VNDA in Q3 2026 at 962,898 shares (US$19.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 962.90K | $19.20M | New |
About VNDA and 13F data
VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in VNDA — the largest reported positions include ORBIMED ADVISORS LLC (US$482.7M), SR ONE CAPITAL MANAGEMENT, LP (US$198.1M), Bain Capital Life Sciences Investors, LLC (US$134.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VNDA
- ORBIMED ADVISORS LLC 24.21M sh · $482.66M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 9.94M sh · $198.14M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 6.73M sh · $134.18M · Q3 2026
- TCG Crossover Management, LLC 4.12M sh · $82.08M · Q3 2026
- Siren, L.L.C. 1.93M sh · $38.40M · Q3 2026
- Venrock Adviser, LLC 1.63M sh · $32.42M · Q3 2026
- Commodore Capital LP 1.26M sh · $25.14M · Q3 2026
- EcoR1 Capital, LLC 1.15M sh · $22.93M · Q3 2026
- Redmile Group, LLC 769.35K sh · $15.34M · Q3 2026
- AIGH Capital Management LLC 2.25M sh · $11.05M · Q3 2026
- GordonMD Global Investments LP 450.00K sh · $8.97M · Q3 2026
- Krensavage Asset Management, LLC 1.18M sh · $7.22M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held VNDA?
Cormorant Asset Management, LP has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Cormorant Asset Management, LP's current position in VNDA?
As of Q3 2026, Cormorant Asset Management, LP holds 962.90K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $19.20M, representing 1.37% of its reported portfolio and ranking #22.
Has Cormorant Asset Management, LP been buying or selling VNDA?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in VNDA.
Which other funds hold VNDA?
Other major institutional holders of VNDA include ORBIMED ADVISORS LLC, SR ONE CAPITAL MANAGEMENT, LP, Bain Capital Life Sciences Investors, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.